{"id":"https://openalex.org/W4220715693","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16","title":"Abstract P4-01-16: Overcome chemoresistance of triple-negative breast cancer by inhibiting the RNA-binding protein HuR","display_name":"Abstract P4-01-16: Overcome chemoresistance of triple-negative breast cancer by inhibiting the RNA-binding protein HuR","publication_year":2022,"publication_date":"2022-02-15","ids":{"openalex":"https://openalex.org/W4220715693","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs21-p4-01-16","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091826762","display_name":"Lanjing Wei","orcid":"https://orcid.org/0000-0001-9170-0931","observed_orcids":["https://orcid.org/0000-0001-9170-0931"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lanjing Wei","raw_affiliation_strings":["Bioengineering Program, the University of Kansas, Lawrence, KS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bioengineering Program, the University of Kansas, Lawrence, KS;","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100360324","display_name":"Qi Zhang","orcid":"https://orcid.org/0000-0002-5824-2534","observed_orcids":["https://orcid.org/0000-0002-5824-2534"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qi Zhang","raw_affiliation_strings":["Department of Molecular Biosciences, the University of Kansas, Lawrence, KS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biosciences, the University of Kansas, Lawrence, KS;","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055955475","display_name":"Cuncong Zhong","orcid":"https://orcid.org/0000-0002-8777-082X","observed_orcids":["https://orcid.org/0000-0002-8777-082X"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cuncong Zhong","raw_affiliation_strings":["Department of Electrical Engineering and Computer Science, The University of Kansas, Lawrence, KS;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Electrical Engineering and Computer Science, The University of Kansas, Lawrence, KS;","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088422127","display_name":"Jeffrey Aub\u00e9","orcid":"https://orcid.org/0000-0003-1049-5767","observed_orcids":["https://orcid.org/0000-0003-1049-5767"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Aub\u00e9","raw_affiliation_strings":["Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, NC;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, The University of North Carolina, Chapel Hill, NC;","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056217370","display_name":"Danny R. Welch","orcid":"https://orcid.org/0000-0002-1951-4947","observed_orcids":["https://orcid.org/0000-0002-1951-4947"]},"institutions":[{"id":"https://openalex.org/I4210097601","display_name":"The University of Kansas Cancer Center","ror":"https://ror.org/00cj35179","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210097601"]},{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danny R. Welch","raw_affiliation_strings":["Department of Cancer Biology, The University of Kansas Medical Center; The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS;","The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Biology, The University of Kansas Medical Center; The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS;","institution_ids":["https://openalex.org/I4210097601","https://openalex.org/I4210128618"]},{"raw_affiliation_string":"The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS","institution_ids":["https://openalex.org/I4210097601","https://openalex.org/I4210128618"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101222578","display_name":"Xiaoqing Wu","orcid":"https://orcid.org/0009-0008-9958-8655","observed_orcids":["https://orcid.org/0009-0008-9958-8655"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]},{"id":"https://openalex.org/I4210097601","display_name":"The University of Kansas Cancer Center","ror":"https://ror.org/00cj35179","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210097601"]},{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoqing Wu","raw_affiliation_strings":["Department of Molecular Biosciences, The University of Kansas; The University of Kansas Cancer Center, The University of Kansas Medical Center, Lawrence, KS;","Department of Molecular Biosciences, The University of Kansas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biosciences, The University of Kansas; The University of Kansas Cancer Center, The University of Kansas Medical Center, Lawrence, KS;","institution_ids":["https://openalex.org/I146416000","https://openalex.org/I4210097601","https://openalex.org/I4210128618"]},{"raw_affiliation_string":"Department of Molecular Biosciences, The University of Kansas","institution_ids":["https://openalex.org/I146416000"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112751849","display_name":"Liang Xu","orcid":"https://orcid.org/0000-0002-0726-2041","observed_orcids":["https://orcid.org/0000-0002-0726-2041"]},"institutions":[{"id":"https://openalex.org/I146416000","display_name":"University of Kansas","ror":"https://ror.org/001tmjg57","country_code":"US","type":"education","lineage":["https://openalex.org/I146416000"]},{"id":"https://openalex.org/I4210097601","display_name":"The University of Kansas Cancer Center","ror":"https://ror.org/00cj35179","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210097601"]},{"id":"https://openalex.org/I4210128618","display_name":"University of Kansas Medical Center","ror":"https://ror.org/036c9yv20","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128618"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Liang Xu","raw_affiliation_strings":["Department of Molecular Biosciences, the University of Kansas; The University of Kansas Cancer Center, The University of Kansas Medical Center; Department of Radiation Oncology, The University of Kansas Medical Center, Lawrence, KS","Department of Molecular Biosciences, the University of Kansas","The University of Kansas Cancer Center, The University of Kansas Medical Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biosciences, the University of Kansas; The University of Kansas Cancer Center, The University of Kansas Medical Center; Department of Radiation Oncology, The University of Kansas Medical Center, Lawrence, KS","institution_ids":["https://openalex.org/I146416000","https://openalex.org/I4210097601","https://openalex.org/I4210128618"]},{"raw_affiliation_string":"Department of Molecular Biosciences, the University of Kansas","institution_ids":["https://openalex.org/I146416000"]},{"raw_affiliation_string":"The University of Kansas Cancer Center, The University of Kansas Medical Center","institution_ids":["https://openalex.org/I4210097601","https://openalex.org/I4210128618"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"4_Supplement","first_page":"P4","last_page":"01"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.9330999851226807,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.057500001043081284,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.878000020980835},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.9599999785423279},{"id":"https://openalex.org/keywords/hur","display_name":"HuR","score":0.9679999947547913},{"id":"https://openalex.org/keywords/rna-binding-proteins","display_name":"RNA-binding proteins","score":0.7179999947547913},{"id":"https://openalex.org/keywords/mrna-stabilization","display_name":"mRNA stabilization","score":0.5690000057220459},{"id":"https://openalex.org/keywords/post-transcriptional-regulation","display_name":"post-transcriptional regulation","score":0.8040000200271606},{"id":"https://openalex.org/keywords/docetaxel-resistance","display_name":"docetaxel resistance","score":0.9380000233650208},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":1.0},{"id":"https://openalex.org/keywords/chemosensitization","display_name":"chemosensitization","score":0.8330000042915344},{"id":"https://openalex.org/keywords/synergistic-drug-combination","display_name":"synergistic drug combination","score":0.7009999752044678},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.8259999752044678},{"id":"https://openalex.org/keywords/orthotopic-xenograft-model","display_name":"orthotopic xenograft","score":0.6700000166893005},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.7728927731513977},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6197324395179749},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.6065751314163208},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6058655381202698},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5431503653526306},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5270771384239197},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.5129720568656921},{"id":"https://openalex.org/C119056186","wikidata":"https://www.wikidata.org/wiki/Q1431332","display_name":"Gene silencing","level":3,"score":0.5073811411857605},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.49036312103271484},{"id":"https://openalex.org/C41282012","wikidata":"https://www.wikidata.org/wiki/Q3928341","display_name":"RNA-binding protein","level":4,"score":0.489460825920105},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4449879825115204},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.429014652967453},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4142787456512451},{"id":"https://openalex.org/C149364088","wikidata":"https://www.wikidata.org/wiki/Q185917","display_name":"Translation (biology)","level":4,"score":0.41260457038879395},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4116075932979584},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3726389706134796},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2975460886955261},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.1625574231147766},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.06919953227043152}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs21-p4-01-16","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p4-01-16","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4250517092","https://openalex.org/W4282914540","https://openalex.org/W4225409671","https://openalex.org/W3133042475","https://openalex.org/W4362593550","https://openalex.org/W4322771416","https://openalex.org/W4382011332","https://openalex.org/W3013678603","https://openalex.org/W2477826913","https://openalex.org/W7148972876"],"abstract_inverted_index":{"Abstract":[0],"Chemotherapy":[1],"remains":[2],"the":[3,58,141,149,182,199,235,239,258,263,280,292,323,331,345,409,417],"primary":[4],"systemic":[5],"treatment":[6,302,328],"for":[7,155,203,378],"triple-negative":[8,404],"breast":[9,38,88,405],"cancer":[10,106,113,406],"(TNBC).":[11],"However,":[12,352],"patients":[13],"with":[14,34,80,137,223,283],"TNBC":[15,187,360],"often":[16],"develop":[17],"resistance":[18,225,347,381],"to":[19,98,100,115,123,180,207,226,234,246,253,348,361],"conventional":[20],"chemotherapy,":[21],"resulting":[22],"in":[23,64,102,186,257,293,303,318,322,344],"a":[24,28,48,120,160,288,375],"poorer":[25],"prognosis":[26],"and":[27,56,83,108,146,190,248,255,262,306,326,350],"higher":[29],"recurrence":[30],"rate":[31],"than":[32],"those":[33],"other":[35],"subtypes":[36],"of":[37,60,67,76,87,105,110,130,143,152,184,201,215,356,372,382,403,416],"cancer.":[39,89],"The":[40,72,90,275,335],"RNA-binding":[41,410],"protein":[42,411],"Hu":[43],"antigen":[44],"R":[45],"(HuR)":[46],"is":[47,78,119,374],"posttranscriptional":[49],"regulator,":[50],"which":[51,166],"can":[52,139,197,271,329],"stabilize":[53],"target":[54,122,144,315],"mRNAs":[55,145,316],"regulate":[57],"translation":[59,150],"encoded":[61],"proteins":[62,153],"implicated":[63,317],"several":[65,103,312,340],"hallmarks":[66],"cancer,":[68],"including":[69],"drug":[70],"resistance.":[71],"high":[73],"cytoplasmic":[74,92],"expression":[75],"HuR":[77,93,111,118,131,163,169,185,193,210,269,313,373,412],"associated":[79],"high-grade":[81],"malignancy":[82],"poor":[84],"clinical":[85],"outcomes":[86],"accumulated":[91],"has":[94,287],"also":[95],"been":[96],"reported":[97,159],"contribute":[99],"chemoresistance":[101,188,214,319,402],"types":[104],"cells":[107,114,252],"inhibition":[109,129,194,211,270,371],"sensitizes":[112,359],"chemotherapy.":[116],"Therefore,":[117],"promising":[121,376],"overcome":[124,272],"chemoresistance.":[125,274],"We":[126],"hypothesize":[127],"that":[128,268,279,298,339,370],"function":[132,170],"by":[133,171,195,407],"disrupting":[134,172],"its":[135],"interaction":[136],"mRNA":[138,333],"accelerate":[140],"decay":[142],"thus":[147],"reduce":[148],"level":[151],"responsible":[154],"chemoresistance.Recently,":[156],"our":[157],"lab":[158],"small":[161],"molecule":[162],"inhibitor,":[164],"KH-3,":[165,247],"potently":[167],"inhibits":[168],"HuR-mRNA":[173],"interactions.":[174],"In":[175,205],"this":[176],"study,":[177],"we":[178,217],"aim":[179],"investigate":[181],"functions":[183],"formation":[189,265],"evaluate":[191],"whether":[192,209],"KH-3":[196,249,282,299,327,358],"enhance":[198],"efficacy":[200,295],"chemotherapy":[202,362,380],"TNBC.":[204,383],"order":[206],"determine":[208],"overcomes":[212],"acquired":[213,224,273,346],"TNBC,":[216],"generated":[218],"two":[219,240],"MDA-MB-231":[220,305],"cell":[221,237],"sub-lines":[222,242],"docetaxel":[227,254,284,301,349],"(231-TR)":[228],"or":[229],"doxorubicin":[230,256,286],"(231-DR),":[231],"respectively.":[232],"Compared":[233],"parental":[236],"line,":[238],"resistant":[241,324],"exhibit":[243],"similar":[244],"sensitivity":[245],"re-sensitizes":[250],"chemoresistant":[251],"MTT-based":[259],"cytotoxicity":[260],"assay":[261],"colony":[264],"assay,":[266],"indicating":[267],"combination":[276,281],"index":[277],"suggests":[278,338,369],"or.":[285],"synergistic":[289],"effect.":[290],"Moreover,":[291],"vivo":[294],"studies":[296],"confirm":[297],"synergized":[300],"both":[304],"231-TR":[307],"orthotopic":[308],"xenograft":[309],"models.":[310],"Mechanistically,":[311],"direct":[314],"are":[320,363],"upregulated":[321],"cells,":[325],"reverse":[330],"enhanced":[332],"levels.":[334],"bioinformatic":[336],"analysis":[337],"pathways":[341],"may":[342],"involve":[343],"doxorubicin.":[351],"detailed":[353],"molecular":[354],"mechanisms":[355],"how":[357],"still":[364],"under":[365],"investigation.":[366],"This":[367],"study":[368],"strategy":[377],"overcoming":[379],"Citation":[384],"Format:":[385],"Lanjing":[386],"Wei,":[387],"Qi":[388],"Zhang,":[389],"Cuncong":[390],"Zhong,":[391],"Jeffrey":[392],"Aub\u00e9,":[393],"Danny":[394],"R.":[395],"Welch,":[396],"Xiaoqing":[397],"Wu,":[398],"Liang":[399],"Xu.":[400],"Overcome":[401],"inhibiting":[408],"[abstract].":[413],"In:":[414],"Proceedings":[415],"2021":[418,424],"San":[419,427],"Antonio":[420],"Breast":[421],"Cancer":[422,433],"Symposium;":[423],"Dec":[425],"7-10;":[426],"Antonio,":[428],"TX.":[429],"Philadelphia":[430],"(PA):":[431],"AACR;":[432],"Res":[434],"2022;82(4":[435],"Suppl):Abstract":[436],"nr":[437],"P4-01-16.":[438]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2022-04-03T00:00:00"}